On January 13, the Committee on Foreign Investment in the United States (CFIUS) published the final rules implementing the Foreign Investment Risk Review Modernization Act (FIRRMA).
Health Law Scan
Legal Insights and Perspectives for the Healthcare Industry
In this LawFlash, our white collar litigation and government investigations team unpacks the fiscal year 2019 False Claims Act (FCA) recovery statistics recently announced by the US Department of Justice.
The Medicare Payment Advisory Commission (MedPAC), which advises Congress on Medicare issues, recently finalized and approved a series of recommended updates on January 16 that include payment reductions for hospice and home health.
From seismic changes to the fraud and abuse laws to new legislation on drug price transparency, we have compiled a list of the 10 most popular blog posts from Health Law Scan in 2019.
In a recent analysis for Today’s General Counsel, healthcare industry partner Katie McDermott analyzes the US Court of Appeals for the Eleventh Circuit’s decision in United States v. AseraCare, Inc. and offers key takeaways for False Claims Act (FCA) practitioners from “this reasoned and scholarly opinion.”
As discussed in an earlier blog post, US President Donald Trump signed the Further Consolidated Appropriations Act, 2020, into law on December 20, 2019.
The recently passed FY 2020 Appropriations Act increases funding for US healthcare agencies and programs over FY 2019 levels.
In this LawFlash, Morgan Lewis healthcare industry partner Susan Feigin Harris analyzes the December 18, 2019, decision by the US Court of Appeals for the Fifth Circuit in Texas v. Azar and concludes that it “portends potential chaos in health insurance coverage and puts the future of the entire Patient Protection and Affordable Care Act (ACA) in limbo.”